INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $131M invested in Infinity Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
Holders
97
Holding in Top 10
–
Calls
$2.06M
Puts
$1.33M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$5.27M | |
| 3 | +$3.99M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.51M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.3M |
Top Sellers
| 1 | -$8.4M | |
| 2 | -$5.33M | |
| 3 | -$3.91M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.37M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.63M |